miRNA-148a Enhances the Treatment Response of Patients with Rectal Cancer to Chemoradiation and Promotes Apoptosis by Directly Targeting <i>c-Met</i>

miRNA-148a Enhances the Treatment Response of Patients with Rectal Cancer to Chemoradiation and Promotes Apoptosis by Directly Targeting <i>c-Met</i>

Patients with locally advanced rectal cancer (LARC) who achieve a pathological complete response (pCR) to neoadjuvant chemoradiotherapy (NACRT) have an excellent prognosis, but only approximately 30% of patients achieve pCR. Therefore, identifying predictors of pCR is imperative. We employed a micro...

Full description

Bibliographic Details
Main Authors: Chun-Ming Huang, Ming-Yii Huang, Yen-Cheng Chen, Po-Jung Chen, Wei-Chih Su, Tsung-Kun Chang, Ching-Chun Li, Ching-Wen Huang, Hsiang-Lin Tsai, Jaw-Yuan Wang
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Biomedicines
Subjects:
miRNA-148a
rectal cancer
chemoradiotherapy
apoptosis
<i>c-Met</i>
Online Access:https://www.mdpi.com/2227-9059/9/10/1371

Internet

https://www.mdpi.com/2227-9059/9/10/1371

Similar Items